United Therapeutics Corp vs Johnson & Johnson
UTHR vs JNJ — side-by-side comparison from reported financials. UTHR leads 5, JNJ leads 4 of 9 comparable metrics.
United Therapeutics Corp
UTHR · Healthcare
$549.16+3.07%Strong
Johnson & Johnson
JNJ · Healthcare
$261.79+2.07%Mixed
| Metric | UTHR | JNJ |
|---|---|---|
| Price | $549.16 | $261.79 |
| Market cap | $23.6B | $631B |
| Revenue (TTM) | $3.15B | $97.9B |
| Revenue growth | +18.0% | +5.6% |
| Net margin | 41.6% | 21.5% |
| Free cash flow | $1.09B | $22.2B |
| Net cash (debt) | $2.88B | ($27.8B) |
| 1-year price return | +23.3% | +37.0% |
| P/E | 18.0 | 29.9 |
| P/E vs own history (cheap-side %) | 26% | 16% |
| Dividend yield | — | 2.00% |
| Return on equity | 20% | 26% |
| Altman Z-score | 21.46 | — |
| CV checks passed | 10 of 10 | 10 of 10 |
| Employees | 1,400 | 140,800 |
Full résumé-style profiles: UTHR CV · JNJ CV
Green marks the stronger side on comparable metrics. Figures are derived from company filings and may be delayed, restated or incomplete — information, not investment advice.